Target Gene/Pathway(薬物標的遺伝子/パスウェイリスト)💬 Info on mouse-over

11 / 286 pathways

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Adrenergic signaling in cardiomyocytes 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D00680 💬 Methylergometrine 2件: 118, 288 💬
2 Adrenergic signaling in cardiomyocytes 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D08207 💬 Methylergometrine 2件: 118, 288 💬
3 Adrenergic signaling in cardiomyocytes 💬
1件: ADRB2 💬 D00688 💬 Terbutaline 1件: 118 💬
4 Adrenergic signaling in cardiomyocytes 💬
1件: ADRB2 💬 D08570 💬 Terbutaline 1件: 118 💬
5 AMPK signaling pathway 💬
1件: ADRA1A 💬 D00680 💬 Methylergometrine 2件: 118, 288 💬
6 AMPK signaling pathway 💬
1件: ADRA1A 💬 D08207 💬 Methylergometrine 2件: 118, 288 💬
7 Calcium signaling pathway 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D00680 💬 Methylergometrine 2件: 118, 288 💬
8 Calcium signaling pathway 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D08207 💬 Methylergometrine 2件: 118, 288 💬
9 Calcium signaling pathway 💬
1件: ADRB2 💬 D00688 💬 Terbutaline 1件: 118 💬
10 Calcium signaling pathway 💬
1件: ADRB2 💬 D08570 💬 Terbutaline 1件: 118 💬
11 Calcium signaling pathway 💬
1件: OXTR 💬 D03008 💬 Atosiban 1件: 118 💬
12 cAMP signaling pathway 💬
1件: ADRB2 💬 D00688 💬 Terbutaline 1件: 118 💬
13 cAMP signaling pathway 💬
1件: ADRB2 💬 D08570 💬 Terbutaline 1件: 118 💬
14 cAMP signaling pathway 💬
1件: OXTR 💬 D03008 💬 Atosiban 1件: 118 💬
15 cGMP-PKG signaling pathway 💬
6件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬 D00680 💬 Methylergometrine 2件: 118, 288 💬
16 cGMP-PKG signaling pathway 💬
6件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬 D08207 💬 Methylergometrine 2件: 118, 288 💬
17 cGMP-PKG signaling pathway 💬
1件: ADRB2 💬 D00688 💬 Terbutaline 1件: 118 💬
18 cGMP-PKG signaling pathway 💬
1件: ADRB2 💬 D08570 💬 Terbutaline 1件: 118 💬
19 Neuroactive ligand-receptor interaction 💬
6件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬 D00680 💬 Methylergometrine 2件: 118, 288 💬
20 Neuroactive ligand-receptor interaction 💬
6件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬 D08207 💬 Methylergometrine 2件: 118, 288 💬
21 Neuroactive ligand-receptor interaction 💬
1件: ADRB2 💬 D00688 💬 Terbutaline 1件: 118 💬
22 Neuroactive ligand-receptor interaction 💬
1件: ADRB2 💬 D08570 💬 Terbutaline 1件: 118 💬
23 Neuroactive ligand-receptor interaction 💬
1件: OXTR 💬 D03008 💬 Atosiban 1件: 118 💬
24 Oxytocin signaling pathway 💬
1件: OXTR 💬 D03008 💬 Atosiban 1件: 118 💬
25 Regulation of lipolysis in adipocytes 💬
1件: ADRB2 💬 D00688 💬 Terbutaline 1件: 118 💬
26 Regulation of lipolysis in adipocytes 💬
1件: ADRB2 💬 D08570 💬 Terbutaline 1件: 118 💬
27 Renin secretion 💬
1件: ADRB2 💬 D00688 💬 Terbutaline 1件: 118 💬
28 Renin secretion 💬
1件: ADRB2 💬 D08570 💬 Terbutaline 1件: 118 💬
29 Salivary secretion 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D00680 💬 Methylergometrine 2件: 118, 288 💬
30 Salivary secretion 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D08207 💬 Methylergometrine 2件: 118, 288 💬
31 Salivary secretion 💬
1件: ADRB2 💬 D00688 💬 Terbutaline 1件: 118 💬
32 Salivary secretion 💬
1件: ADRB2 💬 D08570 💬 Terbutaline 1件: 118 💬
33 Vascular smooth muscle contraction 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D00680 💬 Methylergometrine 2件: 118, 288 💬
34 Vascular smooth muscle contraction 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 D08207 💬 Methylergometrine 2件: 118, 288 💬